VERICEL CORPORATION Public Float
VERICEL CORPORATION (VCEL) had Public Float of $2.10 billion as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $2.10B.
- 2024-06-30: Entity Public Float $2.20B.
- 2023-06-30: Entity Public Float $1.77B.
- 2022-06-30: Entity Public Float $1.18B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $2.10B 10-K · filed 2026-02-26 |
| 2024-06-30 | $2.20B 10-K · filed 2025-02-27 |
| 2023-06-30 | $1.77B 10-K · filed 2024-02-29 |
| 2022-06-30 | $1.18B 10-K · filed 2023-02-23 |
| 2021-06-30 | $2.43B 10-K · filed 2022-02-24 |
| 2020-06-30 | $617.74M 10-K · filed 2021-02-24 |
| 2019-06-30 | $827.62M 10-K · filed 2020-02-25 |
| 2018-06-30 | $412.77M 10-K · filed 2019-02-26 |
| 2017-06-30 | $107.97M 10-K · filed 2018-03-05 |
| 2016-06-30 | $54.89M 10-K · filed 2017-03-13 |
| 2015-06-30 | $86.92M 10-K · filed 2016-03-14 |
| 2014-06-27 | $28.49M 10-K · filed 2015-03-25 |
| 2013-06-28 | $18.24M 10-K · filed 2014-03-13 |
| 2012-06-29 | $91.12M 10-K · filed 2013-03-18 |
| 2011-06-30 | $105.71M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |